Page 66 - Pharma

Ranbaxy inks licensing pact with Canada's Cipher to sell acne drug in Brazil

Cipher will supply isotretinoin (used to treat severe acne), Ranbaxy will be responsible for gaining regulatory approval of the product in Brazil

IPCA Labs stops shipments to US after receiving FDA alert for MP unit

Sales of the company is expected to be hit with a loss of Rs 150 crore in next six months

Indoco Remedies facilities receive USFDA nod

US drug regulator has granted approvals for the company's sterile and solid dosage manufacturing facilities

Strides Arcolab buys stake in Bafna's branded generics biz for Rs 48 cr

Agreement to boost Strides Arcolab's branded generics business as it picks up global rights for Bafna Pharma's flagship brand Rericap

IOL Chemicals receives GMP certificate from Germany

GMP certificate will boost the company's ibuprofen sale in Europe

NPPA's move to put price control on more drugs to hurt pharma industry

The fresh move to bring diabetes and cardiovascular medicines under price control regime could result in a loss of around Rs 600 crore to the industry

Cipla acquires monoclonal antibodies maker Mabpharm

Mabpharm, a manufacturer of monoclonal antibodies for treatment of cancer and auto-immune diseases, will now become a wholly-owned subsidiary of Cipla

Glenmark to set up manufacturing facility in the US

The facility, which will be Glenmark's first manufacturing facility in North America, will include three units that will produce oral solids, injectables and topicals

Cipla, Mylan, Micro Labs, Aurobindo, Emcure ink licensing pact for antiretrovirals with a UN unit

Medicines Patent Pool has signed seven new sub-licences for generic HIV medicines with Cipla, Mylan, Micro Labs, Aurobindo, Laurus Labs, Emcure and Desano (a Chinese manufacturer)

Mumbai HC judgement to give fillip to nutraceutical industry

Indian Drug Manufacturers' Association (IDMA) says food producers can now continue unhindered manufacturing of nutraceuticals

Glenmark receives USFDA approval for fluocinonide cream

As per IMS Health, fluocinonide cream garnered annual sales of approximately $ 103 million in the 12 month period ending March 2014

Sun Pharma buys injectables maker Pharmalucence in USA

Pharmalucence, a sterile injectable capacity in the US, was acquired by one of Sun's US subsidiaries

Government to set up R&D centre for bulk drugs at NIPER

The centre, to be located in Hyderabad, will offer competitive and eco-friendly technologies in specified areas products and processes

Pharma sector did not receive its due attention in the budget

There was much left to be desired in terms of clarifying and answering the many questions that all the pharma industry stakeholders have in mind

Budget fell short of expectations: Ramesh Swaminathan, CFO, Lupin

The budget is unequivocally positive for the infrastructure, manufacturing and banking sectors; however, no incentives were given to the pharma industry

DSM to acquire Chinese vitamin C maker Aland

The move will further strengthen DSM's position in vitamin C market

Government to strengthen state drug and food regulatory systems

Also proposes to set up 15 rural health research centres, which will take up research on local health issues concerning rural population

European Commission slaps Rs 575-cr fine on Lupin, Matrix and Unichem

The commission has slapped a hefty fine of Euro 427.7 million (Rs 3,458.7 cr) on five generic drug manufacturers (including 3 Indian firms) and French company Servier for blocking hypertension generic

Glenmark receives USFDA approval for telmisartan tablets

Telmisartan, which is the generic version of Boehringer Ingelheim's Micardis, garnered annual sales of $ 250 million for the 12 month period ending March 2014

Claris Lifesciences facility receives USFDA's positive nod

US drug regulator termed Claris' facility as acceptable after the inspection